APA (7th ed.) Citation

Cotter, A., Wallace, D., McCarthy, C., Feeney, E., O'Neill, L., Stack, J., . . . Mallon, P. (2020). The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(1), N.PAG. https://doi.org/10.1186/s13063-020-04680-w

Chicago Style (17th ed.) Citation

Cotter, Aoife, et al. "The COVIRL002 Trial-Tocilizumab for Management of Severe, Non-critical COVID-19 Infection: A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials 21, no. 1 (2020): N.PAG. https://doi.org/10.1186/s13063-020-04680-w.

MLA (9th ed.) Citation

Cotter, Aoife, et al. "The COVIRL002 Trial-Tocilizumab for Management of Severe, Non-critical COVID-19 Infection: A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials, vol. 21, no. 1, 2020, p. N.PAG, https://doi.org/10.1186/s13063-020-04680-w.